Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. MIRENA (levonorgestrel)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MIRENA (levonorgestrel)

Medicine - Posted on Feb 24 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • levonorgestrel
history (5)
  • 2/8/17

    MIRENA (levonorgestrel)

    Maintien du remboursement dans les mêmes conditions
    CAV :
    54321
    icône flèche
  • 2/6/13

    MIRENA (levonorgestrel)

    MIRENA (levonorgestrel)
    CAV :
    54321
    icône flèche
  • 2/28/07

    MIRENA (levonorgestrel)

    MIRENA (levonorgestrel)
    icône flèche
  • 3/30/05

    MIRENA 52 mg (20 mg/24h), dispositif intra-utérin

    MIRENA 52 mg (20 mg/24h), dispositif intra-utérin
    icône flèche
  • 2/7/01

    MIRENA 52 mg (20 microgrammes / 24 heures), dispositif intra-utérin en poche (boîte de 1)

    MIRENA 52 mg (20 microgrammes / 24 heures), dispositif intra-utérin en poche (boîte de 1)
    icône flèche
Technical information
ATC code
  • G02BA03
Manufacturer
BAYER HEALTHCARE SAS
Presentation

MIRENA 52 mg (20 microgrammes/24 heures), dispositif intra-utérin (code CIS : 66349230) 1 plaquette(s) polytéréphtalate (PET) polyéthylène de 1 dispositif(s) - Code CIP : 3400933929282

All our publications
    Contraception, abortion and sterilization Drug therapy Female genital diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
7UfQT6PvqcdSz67e